Despite evidence that vaccinating healthcare workers against influenza helps to protect patients, many still refuse — even during the worst flu season in nearly a decade.
The plasma industry continues to plan and invest for the future to assure that immunoglobulin, albumin and other life-critical plasma products are on the shelf when they’re needed.
Early referral for workup of patients with any of more than 150 occult primary immunodeficiency diseases can dramatically reduce hospitalizations, permanent disability and high costs of care.
Researchers investigated the efficacy, safety and pharmacokinetics and quality of life impact of Evogam, a new chromatographically fractionated 16% subcutaneous immunoglobulin (SCIG).
The hepatitis C virus affects 130 million to 170 million people worldwide, and the numbers are growing. But with a better understanding of the disease and advances in treatment, it no longer has to be a death sentence for most.
Billing for reimbursement of this costly, lifesaving therapy can be complicated, but for the sake of the provider and the patient, getting it right the first time can shorten approval time and prevent denials.
While a cure remains elusive, strides in treatment options are increasingly controlling symptoms and giving patients a positive long-term prognosis.
Advances in research are showing promise for new treatments for this chronic and disabling disease.
Billing codes used to seek reimbursement for Hizentra, including supplies, pump and nursing, for a primary immunodeficiency disease
6% hydroxyethyl starch products have been touted as a less-expensive alternative to 5% human albumin for blood volume expansion, but recent published evidence shows that it comes at a price for selected populations.
Despite the widespread belief that asthma is not serious, it’s a potentially lethal illness that can be managed by understanding the facts about how to prevent and treat asthma attacks.
With the rising rates of autoimmune disease, the quest is on to research and develop new medicines to treat patients who often present with multiple disorders.